Canary Speech Secures $13 Million in Series A

Canary Speech Secures $13 Million in Series A

Canary Speech, a Provo, Utah-based AI-powered voice biomarker health tech company, has secured $13 million in Series A funding.

The round was led by Cortes Capital, LLC, with participation from Sorenson Communications, LLC, SMK (Japan), and Hackensack Meridian Health.

Cortes Capital is a private equity firm based in Oklahoma City, Oklahoma. Cortes Capital is an investment arm of Love's private equity.

The company will use the funding to expand the team and accelerate the company’s growth and technology development.

Founded by Henty O'Connell and Jeff Adams, Canary Speech is an AI voice tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders. Its vocal biomarker technology captures and analyzes speech data within seconds to identify irregularities in behavioral and cognitive changes before current clinical screening standards or noticeable symptoms for invisible illnesses like anxiety, depression, and dementia. Based in Utah, the company advances speech and language applications for health systems, payers, and pharmaceutical markets.

Funding Details

Company: Canary Speech, Inc.

Raised: $13.0M

Round: Series A

Funding Month: June 2024

Lead Investors: Cortes Capital, LLC

Additional Investors: Sorenson Communications, LLC, SMK (Japan), Hackensack Meridian Health

Company Website: https://canaryspeech.com/

Software Category: AI Speech Analysis